4OR.F - Organovo Holdings, Inc.
Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.4368
-0.0010 (-0.23%)
At close: 8:14AM CET
Stock chart is not supported by your current browser
| Previous Close | 0.4378 |
| Open | 0.4368 |
| Bid | 0.4396 x 200000 |
| Ask | 0.4636 x 200000 |
| Day's Range | 0.4368 - 0.4368 |
| 52 Week Range | 0.2188 - 1.0000 |
| Volume | 565 |
| Avg. Volume | 1,544 |
| Market Cap | 59M |
| Beta (5Y Monthly) | 2.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2110 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Benzinga
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) Dova Pharmaceuticals Inc (NASDAQ: DOVA ) Down In The ...
- Benzinga
The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 23.) ArQule, Inc. (NASDAQ: ARQL ) Turning Point ...
Motley FoolOrganovo Holdings (ONVO) Q3 2019 Earnings Conference Call Transcript
ONVO earnings call for the period ending December 31, 2018.
- Associated Press
Organovo: Fiscal 3Q Earnings Snapshot
On a per-share basis, the San Diego-based company said it had a loss of 6 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...